evidence_text: Rep. Green moved to amend the bill as follows:
  
  1. Amend page 222, line 13, after “therapy.” by inserting “The department shall not require prior authorization, step therapy, or other restrictions for medications approved by the United States Food and Drug Administration to treat opioid withdrawal symptom management.”.
  
  The motion prevailed and the amendment was adopted, a majority of the members serving voting therefor.